↓ Skip to main content

Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+ B-Cell Lymphoma in the Rituximab Era

Overview of attention for article published in Journal of Clinical Oncology, April 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

policy
3 policy sources
patent
4 patents

Citations

dimensions_citation
488 Dimensions

Readers on

mendeley
312 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+ B-Cell Lymphoma in the Rituximab Era
Published in
Journal of Clinical Oncology, April 2010
DOI 10.1200/jco.2009.26.2493
Pubmed ID
Authors

Marita Ziepert, Dirk Hasenclever, Evelyn Kuhnt, Bertram Glass, Norbert Schmitz, Michael Pfreundschuh, Markus Loeffler

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 312 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 <1%
Denmark 2 <1%
Portugal 1 <1%
United States 1 <1%
Unknown 306 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 39 13%
Other 36 12%
Researcher 36 12%
Student > Master 31 10%
Student > Bachelor 27 9%
Other 74 24%
Unknown 69 22%
Readers by discipline Count As %
Medicine and Dentistry 185 59%
Biochemistry, Genetics and Molecular Biology 12 4%
Agricultural and Biological Sciences 11 4%
Nursing and Health Professions 5 2%
Pharmacology, Toxicology and Pharmaceutical Science 5 2%
Other 15 5%
Unknown 79 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 April 2024.
All research outputs
#2,377,945
of 25,837,817 outputs
Outputs from Journal of Clinical Oncology
#5,565
of 22,362 outputs
Outputs of similar age
#8,535
of 105,549 outputs
Outputs of similar age from Journal of Clinical Oncology
#26
of 201 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,362 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.1. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 105,549 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 201 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.